AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Understanding what long term capital gains tax rates are can help you manage your investments effectively. Learn the essentials to save more money.
28,035 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Stitch Fix surprised investors with stronger-than-expected results, sparking a notable market move. This article brea...
The crypto market braced for headlines as Circle faced talk of an open USD threat. Analysts argue the pullback in CRC...
As AI accelerators push data centers to new speeds, investors who understood the shift decade ago are reaping outsize...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
XRP has fallen sharply in recent months. This guide explains the risks and how to decide if down months can become ba...
Unlock actionable takeaways from the 2026 earnings call transcript for IFS. This guide translates the quarter’s numbe...
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...
Meta is betting big on subscriptions with Meta One to pair recurring revenue with AI capability. The thing investors ...
A casual taste-test clip by McDonald’s CEO ignited a social-media firestorm. The incident quickly evolved into a broa...
A fresh take on a notable portfolio move: Kettle Hill Capital reveals a sizable Braze stake via a 747,715-share initi...
Nvidia has built an AI powerhouse, but its stock sits at a valuation that invites scrutiny. This guide breaks down wh...